.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Growing evidence suggests that immune dysregulation significantly contributes to the pathophysiology of neurodevelopmental disorders. Specifically, research into the profile of Cytokines in ADHD has identified distinct signatures that distinguish affected adolescents from healthy peers. A recent cross-sectional study analyzed adolescents aged 12 to 18 to explore the balance of T-helper cell subsets and microglial regulatory markers. Furthermore, the findings highlight a shift toward systemic inflammation in those diagnosed with the condition.
The study found that serum levels of several key markers, including IL-12, IL-17, IL-23, IL-4, and IL-10, were significantly higher in the ADHD group. Among these, IL-12 and IL-17 demonstrated the highest diagnostic yield with an AUC of 0.77. Additionally, IL-12 remained a strong independent predictor during multivariate analysis. These results indicate a proinflammatory activation dominated by Th1 and Th17 pathways. However, the elevation of IL-4 and IL-10 suggests a partially compensatory Th2 and Treg response aimed at modulating this inflammation.
Beyond T-cell activity, the study investigated microglia regulatory cytokines like IL-34 and CSF-1. While CSF-1 levels remained stable across groups, IL-34 showed an increase that nearly reached statistical significance. This suggests potential microglial divergence in ADHD pathophysiology. Consequently, these findings underscore the need for multidimensional immunophenotyping in clinical practice. Developing immune-targeted therapeutic strategies could offer a novel approach to managing symptoms in adolescents who do not respond to conventional treatments.
Research has identified significant increases in proinflammatory cytokines such as IL-12, IL-17, and IL-23, alongside compensatory increases in anti-inflammatory markers like IL-4 and IL-10.
Currently, markers like IL-12 and IL-17 show a moderate diagnostic yield (AUC of approximately 0.77). While they are strong predictors, they are not yet used as standalone diagnostic tools in routine clinical practice.
Th1 and Th17 dominance indicates a state of chronic proinflammatory activation, which may impact neural development and neurotransmitter pathways associated with attention and executive function.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study reveals that IL-12 and IL-17 levels are significantly elevated in adolescents with ADHD, pointing to a Th1/Th17-dominated immune profile....
6 months ago
Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today
A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today
The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today
Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
